Isolation of biologically-active exosomes from human plasma

Journal of Immunological Methods

Volumn 411, Issue , 2014, Pages 55-65

  Muller, Laurent ^a,c   Hong, Chang Sook ^a   Stolz, Donna B ^b   Watkins, Simon C ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Exosome characteristics; Exosome isolation; Human plasma; Immunological studies; Size exclusion chromatography

Indexed keywords

CD69 ANTIGEN; DEOXYRIBONUCLEASE; HYALURONIDASE; PLASMA PROTEIN; RIBONUCLEASE; HYALURONOGLUCOSAMINIDASE; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN; TUMOR PROTEIN;

ARTICLE; CANCER PATIENT; CD4+ T LYMPHOCYTE; CELL ISOLATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DENSITY GRADIENT; EFFECTOR CELL; EXOSOME; FLOW CYTOMETRY; FREEZE THAWING; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMAGE QUALITY; IMMUNOSUPPRESSIVE TREATMENT; LYSOSOME; MITOCHONDRION; MOLECULAR WEIGHT; PARTICLE SIZE; PLASMA; PROTEIN EXPRESSION; SUCROSE GRADIENT; THROMBOCYTE; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; ULTRAFILTRATION; WESTERN BLOTTING; BIOSYNTHESIS; BLOOD; BLOOD BUFFY COAT; CELL CULTURE; CHEMISTRY; CLINICAL TRIAL; EXOSOME CHARACTERISTICS; EXOSOME ISOLATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGICAL STUDIES; IMMUNOLOGY; MALE; METABOLISM; NEOPLASM; PATHOLOGY; SIZE-EXCLUSION CHROMATOGRAPHY; ULTRASTRUCTURE;

EXOSOME CHARACTERISTICS; EXOSOME ISOLATION; HUMAN PLASMA; IMMUNOLOGICAL STUDIES; SIZE-EXCLUSION CHROMATOGRAPHY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOOD BUFFY COAT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DEOXYRIBONUCLEASES; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYALURONOGLUCOSAMINIDASE; LECTINS, C-TYPE; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM PROTEINS; NEOPLASMS; RIBONUCLEASES;

EID: 84907090492     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.06.007     Document Type: Article

References (34)

1. Atai N.A., Balaj L., van Veen H., Breakefield X.O., Jarzyna P.A., Van Noorden C.J., Skog J., Maguire C.A. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J. Neuro-Oncol. 2013, 115:343.
2. Bianco N.R., Kim S.H., Morelli A.E., Robbins P.D. Modulation of the immune response using dendritic cell-derived exosomes. Methods Mol. Biol. 2007, 380:443.
3. Canavan J.B., Afzali B., Scotta C., Fazekasova H., Edozie F.C., Macdonald T.T., Hernandez-Fuentes M.P., Lombardi G., Lord G.M. A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood 2012, 119:e57.
4. Clayton A., Court J., Navabi H., Adams M., Mason M.D., Hobot J.A., Newman G.R., Jasani B. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 2001, 247:163.
5. Graner M.W., Alzate O., Dechkovskaia A.M., Keene J.D., Sampson J.H., Mitchell D.A., Bigner D.D. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009, 23:1541.
6. Gyorgy B., Paloczi K., Kovacs A., Barabas E., Beko G., Varnai K., Pallinger E., Szabo-Taylor K., Szabo T.G., Kiss A.A., Falus A., Buzas E.I. Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube. Thromb. Res. 2014, 133:285.
7. Harrington M.G., Fonteh A.N., Oborina E., Liao P., Cowan R.P., McComb G., Chavez J.N., Rush J., Biringer R.G., Huhmer A.F. The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid. Cerebrospinal Fluid Res. 2009, 6:10.
8. Hawari F.I., Rouhani F.N., Cui X., Yu Z.X., Buckley C., Kaler M., Levine S.J. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1297.
9. Jayachandran M., Miller V.M., Heit J.A., Owen W.G. Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J. Immunol. Methods 2012, 375:207.
10. Keller S., Rupp C., Stoeck A., Runz S., Fogel M., Lugert S., Hager H.D., Abdel-Bakky M.S., Gutwein P., Altevogt P. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007, 72:1095.
11. Kim J.W., Wieckowski E., Taylor D.D., Reichert T.E., Watkins S., Whiteside T.L. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 2005, 11:1010.
12. Kim G., Yoo C.E., Kim M., Kang H.J., Park D., Lee M., Huh N. Noble polymeric surface conjugated with zwitterionic moieties and antibodies for the isolation of exosomes from human serum. Bioconjug. Chem. 2012, 23:2114.
13. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9:4997.
14. Mathivanan S., Lim J.W., Tauro B.J., Ji H., Moritz R.L., Simpson R.J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell Proteomics: MCP 2010, 9:197.
15. Montecalvo A., Larregina A.T., Morelli A.E. Methods of analysis of dendritic cell-derived exosome-shuttle microRNA and its horizontal propagation between dendritic cells. Methods Mol. Biol. 2013, 1024:19.
16. Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:13368.
17. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles and friends. J. Cell Biol. 2013, 200:373.
18. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., Geuze H.J. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161.
19. Ruitenberg J.J., Boyce C., Hingorani R., Putnam A., Ghanekar S.A. Rapid assessment of in vitro expanded human regulatory T cell function. J. Immunol. Methods 2011, 372:95.
20. Runz S., Keller S., Rupp C., Stoeck A., Issa Y., Koensgen D., Mustea A., Sehouli J., Kristiansen G., Altevogt P. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 2007, 107:563.
21. Saze Z., Schuler P.J., Hong C-S., Cheng D., Jackson E.K., Whiteside T.L. Adenosine production by human B cell-mediated suppression of activated T cells. Blood 2013, 122:9.
22. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470.
23. Sokolova V., Ludwig A.K., Hornung S., Rotan O., Horn P.A., Epple M., Giebel B. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B: Biointerfaces 2011, 87:146.
24. Street J.M., Barran P.E., Mackay C.L., Weidt S., Balmforth C., Walsh T.S., Chalmers R.T., Webb D.J., Dear J.W. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Transl. Med. 2012, 10:5.
25. Taylor D.D., Lyons K.S., Gercel-Taylor C. Shed membrane fragment-associated markers for endometrial and ovarian cancers. Gynecol. Oncol. 2002, 84:443.
26. Taylor D.D., Gercel-Taylor C., Lyons K.S., Stanson J., Whiteside T.L. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin. Cancer Res. 2003, 9:5113.
27. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569.
28. Thery, C., Amigorena, S., Raposo, G. and Clayton, A., 2006, Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology/ editorial board, Juan S. Bonifacino ... [et al.] Chapter 3, Unit 3 22.
29. Van der Meel R., Krawczyk-Durka M., Van Solinge W.W., Schiffelers R.M. Toward routine detection of extracellular vesicles in clinical samples. Int. J. Lab. Hematol. 2014, 36:244.
30. Vlassov A.V., Magdaleno S., Setterquist R., Conrad R. Exosomes: current knowledge of their composition, biological functions and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 2012, 1820:940.
31. Whiteside T.L. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem. Soc. Trans. 2013, 41:245.
32. Wieckowski E.U., Visus C., Szajnik M., Szczepanski M.J., Storkus W.J., Whiteside T.L. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 2009, 183:3720.
33. Witwer K.W., Buzas E.I., Bemis L.T., Bora A., Lasser C., Lotvall J., Nolte-'t Hoen E.N., Piper M.G., Sivaraman S., Skog J., Thery C., Wauben M.H., Hochberg F. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2013, 2.
34. Yoo C.E., Kim G., Kim M., Park D., Kang H.J., Lee M., Huh N. A direct extraction method for microRNAs from exosomes captured by immunoaffinity beads. Anal. Biochem. 2012, 431:96.